by VIP Ketamine Clinics | Dec 13, 2021 | Ketamine for Chronic Pain, Ketamine for Depression, Ketamine Research, Ketamine Treatment, Uncategorized
Ketamine, first developed in the 1960s as an anesthetic, has progressively been found to treat the symptoms of depression, PTSD, chronic pain, and anxiety. The versatility of this drug does not stop here, as the use of ketamine to treat other conditions continues to...
by VIP Ketamine Clinics | Aug 11, 2021 | Ketamine Research, Ketamine Treatment
COVID-19 was recognized as a disease caused by severe acute respiratory syndrome coronavirus 2 and was declared a pandemic on March 11, 2020. Since this time, there has been an urgent need to develop new treatments for COVID-19 that use easily available and affordable...
by VIP Ketamine Clinics | Aug 3, 2021 | Ketamine for Chronic Pain, Ketamine for Depression, Ketamine Research, Ketamine Treatment, Psychiatric Drugs
Esketamine, marketed by Janssen Pharmaceuticals as Spravato™, made waves when it was approved by the FDA in 2019. This “revolutionary” antidepressant nasal spray drug was touted as an effective option for individuals suffering from treatment-resistant depression—and...
by VIP Ketamine Clinics | Oct 7, 2020 | Ketamine Research, Ketamine Treatment
Ketamine has been around since the 1960s, but has only recently begun to gain traction as a highly effective treatment for anxiety and depression. Because of its history of abuse as a “club drug,” there is some controversy around using ketamine as a treatment for...
by VIP Ketamine Clinics | Aug 26, 2020 | Ketamine Research, Ketamine Treatment
When you hear about MDMA, magic mushrooms, LSD, or ketamine, chances are it’s not life-saving medical breakthroughs that come to mind but rather wild-eyed party kids, or folks on a “journey.” This all-too-common association continues to inhibit research into the...
by VIP Ketamine Clinics | Jul 30, 2020 | Ketamine Research, Ketamine Treatment
A new clinical study is focused on researching the possibility of treating COVID-19 patients with two common and widely available drugs: naltrexone and ketamine. The research is being conducted by the Beaumont Hospital in Royal Oak, Michigan. The goal of this research...
Recent Comments